Patent · US Active

Transgenic animals and methods of use

US12096753B2 · kind B2 · utility

0Cited by
54References
11Claims
0Family size

Inventors

Key dates

Filing dateOct 22, 2020
Grant dateSep 24, 2024
Priority date
Expiry dateAug 26, 2042

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12N2800/30
  • WIPO fieldBiotechnology
  • WIPO sectorChemistry

Abstract

The present invention comprises non-human vertebrate cells and non-human mammals having a genome comprising an introduced partially human immunoglobulin region, said introduced region comprising human VH coding sequences and non-coding VH sequences based on the endogenous genome of the non-human mammal.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.